Cleared Traditional

ANYSCAN-S SPECT IMAGING SYSTEM (K131625) - FDA 510(k) Clearance

Class II Radiology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K131625 · Absolute Imaging Solutions · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 2013
Decision
121d
Days
Class 2
Risk

K131625 is an FDA 510(k) clearance for the ANYSCAN-S SPECT IMAGING SYSTEM. Classified as System, Tomography, Computed, Emission (product code KPS), Class II - Special Controls.

Submitted by Absolute Imaging Solutions (Stokesdale, US). The FDA issued a Cleared decision on October 3, 2013 after a review of 121 days - within the typical 510(k) review window.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.1200 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Radiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Absolute Imaging Solutions devices

Submission Details

510(k) Number K131625 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 04, 2013
Decision Date October 03, 2013
Days to Decision 121 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
14d slower than avg
Panel avg: 107d · This submission: 121d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code KPS System, Tomography, Computed, Emission
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.1200
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - KPS System, Tomography, Computed, Emission

All 148
Devices cleared under the same product code (KPS) and FDA review panel - the closest regulatory comparables to K131625.
Biograph mCT and mCT Flow PET/CT Scanners
K151486 · Siemens Medical Solutions USA, Inc. · Jul 2015
BIOGRAPH TRUE PET/CT FAMILY SOFTWARE
K141971 · Siemens Medical Solutions USA, Inc. · Sep 2014
SYMBIA 6.0
K142006 · Siemens Medical Solutions USA, Inc. · Aug 2014
SYMBIA
K131634 · Siemens Medical Solutions USA, Inc. · Aug 2013
BIOGRAPH MCT FAMILY
K123737 · Siemens Medical Solutions USA, Inc. · Jan 2013
BIOGRAPH MCT FAMILY
K113448 · Siemens Medical Solutions USA, Inc. · Dec 2011